MCGLYNN MARGARET G — SEC Form 4 filings
SEC reporting owner CIK 1215126. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-06 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 15,000 shares, $200,175 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 7,500 shares @ $13.40 ($100,500) in AMICUS THERAPEUTICS, INC., filed 2024-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) | Director | 4 | — | 2 legs · 15,000 sh · $200,175 | 18 |
| NOVAVAX INC (NVAX) | Director | 5 | — | — | 16 |
Form 4 filings — MCGLYNN MARGARET G
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 18,880 · Grant/award (A): 21,270 (derivative) @ $0 · Grant/award (A): 14,180 (derivative) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to issuer (D): 94,631 @ $14.50 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 16,236 (derivative) · Disposition to issuer (D): 19,473 (derivative) · Disposition to issuer (D): 18,574 (derivative) · Disposition to issuer (D): 36,111 (derivative) · +4 more | EDGAR |
| 2025-06-24 | 4 | NOVAVAX INC (NVAX) | Grant/award (A): 28,326 (derivative) @ $6.42 · Grant/award (A): 18,884 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 10,420 @ $0 · Option exercise (M): 10,420 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 20,414 @ $0 · Grant/award (A): 74,872 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | NOVAVAX INC (NVAX) | Grant/award (A): 2,029 @ $4.90 · Grant/award (A): 713 @ $13.93 · Grant/award (A): 778 @ $12.77 · Grant/award (A): 1,178 @ $8.61 | EDGAR |
| 2024-06-14 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 6,670 @ $0 · Option exercise (M): 6,670 (derivative) @ $0 · Grant/award (A): 15,630 (derivative) @ $15.86 · Grant/award (A): 10,420 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 11,847 @ $0 · Grant/award (A): 42,467 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Option exercise (M): 7,500 @ $2.80 · Sale (S): 7,500 @ $13.29 · Option exercise (M): 7,500 @ $2.80 · Sale (S): 7,500 @ $13.40 · Option exercise (M): 7,500 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1215126 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →